Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06033755
Other study ID # REC 2016/1723
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 10, 2018
Est. completion date January 30, 2023

Study information

Verified date September 2023
Source VID Specialized University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aimed to assess if a multidimensional individually tailored intervention, including Norwegian Psychomotor Physiotherapy (NPMP), elements of cognitive behavioural therapy and a rehabilitation plan, helped reduce inspiratory distress and dysfunctional breathing in adolescent athletes with EILO. A mixed methods design, which combined qualitative and quantitative research, was used. Data, including subjective experiences of respiratory distress, findings from NPMP body examinations and objective measurements of lung function and aerobic capacity were gathered before and after a five month intervention involving 18 participants.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date January 30, 2023
Est. primary completion date January 30, 2023
Accepts healthy volunteers No
Gender All
Age group 13 Years to 19 Years
Eligibility Inclusion Criteria: - Adolescent athletes with symptoms of EILO - Referred to Norwegian Psychomotor Physiotherapy Exclusion Criteria: - Other respiratory symptoms - Additional diagnosis

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Norwegian psychomotor physiotherapy
The intervention consisted predominantly of Norwegian Psychomotor Physiotherapy (NPMP) in which participants received individually tailored treatment based on the body examination and reported respiratory distress. NPMP addresses bodily tension, postural de-alignments and dysfunctional breathing patterns. The consultations also included a cognitive dimension, that is a conversation, in which thoughts and behaviours about training and competing were addressed and where participants were provided with "self help" measures that could improve breathing during training and competing. A rehabilitation plan for each participant was designed to limit further impairments and maintaining aerobic capacity without intensifying EILO symptoms. The intervention lasted 5 months.

Locations

Country Name City State
Norway Liv-Jorunn Kolnes Oslo

Sponsors (2)

Lead Sponsor Collaborator
VID Specialized University Norwegian School of Sport Sciences

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Subjective experiences of respiratory distress associated with exercise reported descriptively in an interview pre and post treatment Experiences of respiratory distress were explored through a history taking and in an qualitative interview based on a questionnaire developed by O. Roksund (2012) Larynx in exercising humans - the unexplored bottleneck of the airways. University of Bergen Norway (PhD thesis). The questionnaire is not developed for research purposes, and reliability and validity studies are lacking. It is however, functional as a basis for the pre and post interview in which respiratory distress was explored and is commonly used for the same purpose at Haukeland University hospital in Norway. The reporting was descriptive and qualitative, and no scale or scores were used. Five months
See also
  Status Clinical Trial Phase
Completed NCT02755714 - Atrovent in Exercise Induced Laryngeal Obstruction (EILO) Phase 1/Phase 2
Recruiting NCT04620343 - HelpILO - RCT on EILO Treatment N/A